US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.32

0.0000

Volume:15

Turnover:502.54

Market Cap:13.33M

PE:- -

High:33.32

Open:33.32

Low:33.32

Close:33.32

52wk High:34.86

52wk Low:25.79

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.02

T/O Rate:0.00%

Dividend:0.08

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference

Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating

MT Newswires Live

Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146

THOMSON REUTERS

MediciNova to Participate in Two Investor Conferences in September

Cholesterol Drug Trial Setback Casts Doubt on Multi-Billion Rivalry

Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication

Pharmaceutical Giant's Shares Plunge Nearly 10% Following Triple Clinical Trial Setbacks

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)

Medprin Regenerative Medical Technologies Advances Absorbable Hemostatic Gel to Clinical Trials

Merck KGaA (0O14) Gets a Hold from Barclays

Gilead Sciences (GILD) Receives a Buy from Bernstein

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

Aliko Scientific accelerates global oncology diagnostics push with Partner International deal

CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults

HENGRUI PHARMA Advances Pipeline with SHR-1179 Injection Clinical Trial Approval

Hengrui Pharma Subsidiary Gains Clinical Trial Approval for Weight Management Drug Candidate

Chongqing Zhifei Biological Receives Clinical Trial Approval for Recombinant Rotavirus Subunit Vaccine

Hualan Vaccine's Novel Influenza mRNA Vaccine Clears Clinical Trial Hurdle, No Domestic Competitors Yet

Gan&Lee Pharmaceuticals Begins Phase I Dosing in GZC8072 Obesity and Diabetes Study

Vitura hit by BUPA telehealth shift but reiterates FY2027 growth outlook

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BMED/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.315,"timestamp":1789569257337,"preClose":33.315,"halted":0,"volume":15,"delay":0,"changeRate":0,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-16 13:51:04 EDT","open":33.315,"high":33.315,"low":33.315,"amount":502.54049999999995,"amplitude":0,"askPrice":33.78,"askSize":1000,"bidPrice":33.7,"bidSize":1000,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":33.315,"sharesOutstanding":360000,"nav":33.210436,"aum":13284174.4,"dividendRate":0.002392,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.23,"preClose":33.315,"latestTime":"16:10 EDT","volume":6,"amount":199.89,"timestamp":1789503006991,"change":-0.085,"changeRate":-0.002551,"amplitude":0},"volumeRatio":0.019025,"impliedVol":0.0634,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.019025,"shares":400000,"dividePrice":0.0797,"high":33.315,"amplitude":0,"preClose":33.315,"low":33.315,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":33.315,"eps":0,"divideRate":0.002392,"volume":15,"delay":0,"ttmEps":0,"open":33.315,"prevYearClose":30.32,"prevWeekClose":32.965,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":33.0422,"twentyDayClose":32.666,"sixtyDayClose":28.5621},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665242473","title":"Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665242473","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665242473?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:45","pubTimestamp":1788864348,"startTime":"0","endTime":"0","summary":"Merck CEO Davis, R&D head Li to speak at Morgan Stanley Global Healthcare ConferenceMerck will join Morgan Stanley’s 24th Annual Global Healthcare Conference on Sept. 14, 2026.CEO Robert M. Davis will","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL445tZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4533","LU1069347547.HKD","LU2125909593.SGD","LU1989772923.USD","IE00BLSP4452.SGD","LU0266013472.USD","BK4585","FTXH","IE00B1BXHZ80.USD","JDOC","LU1974910355.USD","LU0265550359.USD","LU0861579265.USD","IE00BSNM7G36.USD","BK4516","IE0002141913.USD","SG9999014559.SGD","LU1116320901.HKD","GDOC","LU0859254822.USD","LU2023250504.SGD","LU1929549753.HKD","IE00B4R5TH58.HKD","SG9999014542.SGD","XLV","LU0965509101.SGD","LU1093756325.SGD","IE0009355771.USD","LU2112291526.USD","LU1934455194.USD","IE00BJT1NW94.SGD","BK4550","LU1585245621.USD","LU2468319806.SGD","LU0980610538.SGD","LU1571399168.USD","LU2433249047.HKD","LU2360032135.SGD","SG9999002224.SGD","SG9999001440.SGD","LU1699723380.USD","LU2361045086.USD","BK4534","SGXZ57979304.SGD","LU0432979614.USD","BMED","LU0130102774.USD","LU1037948541.HKD","LU1989771016.USD","VHT","IE00BJJMRZ35.SGD","LU1061106388.HKD","SG9999001176.USD","LU0289739699.SGD","LU1093756168.USD","LU0648001328.SGD","LU1201861249.SGD","SG9999015358.SGD","LU0868494708.USD","IE00BLSP4239.USD","LU0106261372.USD","LU2089984988.USD","LU0130517989.USD","LU1057294990.SGD","LU0965509010.AUD","BK4559","LU1032466523.USD","IHE","LU0965508806.USD","LU1066051498.USD","RXL","IXJ","LU1430594728.SGD","HRTS","IE000M9KFDE8.USD","LU1066051225.USD","SG9999013999.USD","LU0965509283.SGD","SG9999001176.SGD","LU1116320737.USD","LU2357627491.SGD","LU0006306889.USD","LU0122379950.USD","LU0868494617.USD","BK4588","LU1023059063.AUD","IYH","LU1983299246.USD","LU1291159041.SGD","LU2324357040.USD","LU0098860793.USD","LU0265550946.USD","LU1066051811.HKD","LU2361044949.HKD","LU2125909247.SGD","LU2361044865.SGD","LU2023250843.SGD","LU1066053197.SGD","SG9999015341.SGD","LU0689626769.HKD","FHLC","LU2491050154.USD","LU1037948897.HKD","SG9999014567.USD","TRUH","LU0320765489.SGD","LU0942090050.USD","LU2491049909.HKD","SG9999014575.USD","IE00BBT3K403.USD","LU2125154935.USD","LU0208291251.USD","LU0985320562.USD","LU0203347892.USD","PPH","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU1941712348.USD","LU0234572021.USD","LU1934455863.HKD","LU2125154778.USD","LU2461242641.AUD","SG9999002232.USD","LU1934455277.USD","LU2106854487.HKD","LU1923622614.USD","LU1989772840.SGD","LU1162221912.USD","LU1035773651.USD","LU0070302665.USD","LU2491050071.SGD","LU1941712264.USD","LU0320765646.SGD","LU0477156953.USD","LU0203345920.USD","LU0238689110.USD","PAWZ","MRK","LU0211331839.USD","LU0124676726.USD","LU0823416689.USD","IE00B2B36J28.USD","LU1917777945.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324477","title":"Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324477","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324477?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:42","pubTimestamp":1788864129,"startTime":"0","endTime":"0","summary":"Merck & Co. (MRK) has an average rating of overweight and mean price target of $149.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BSNM7G36.USD","LU1934455277.USD","HRTS","LU2360032135.SGD","LU0432979614.USD","LU2112291526.USD","LU1066051811.HKD","BK4559","LU0106261372.USD","LU0859254822.USD","LU0203347892.USD","LU1571399168.USD","MRK","LU0965509101.SGD","SG9999014559.SGD","LU0942090050.USD","VHT","PAWZ","SGXZ57979304.SGD","PPH","SG9999001440.SGD","BK4550","LU2125909247.SGD","LU1093756168.USD","LU2357627491.SGD","LU1116320901.HKD","LU0289739699.SGD","JDOC","LU2125909593.SGD","LU2491050154.USD","LU0208291251.USD","LU0985320562.USD","LU1699723380.USD","IE00BJT1NW94.SGD","BK4516","LU1923622614.USD","LU1023059063.AUD","LU0006306889.USD","FTXH","LU1989771016.USD","LU1917777945.USD","IE00BJJMRZ35.SGD","IYH","LU2461242641.AUD","LU2491050071.SGD","LU0648001328.SGD","LU1093756325.SGD","SG9999001176.USD","LU0965509283.SGD","GDOC","BMED","SG9999002224.SGD","LU0211331839.USD","LU1983299246.USD","LU0058720904.USD","IE00B2B36J28.USD","SG9999015341.SGD","LU0320765646.SGD","LU0823416689.USD","LU0965509010.AUD","IE00BN8TJ469.HKD","LU1934455194.USD","LU1934455863.HKD","IE0009355771.USD","LU1035773651.USD","LU2433249047.HKD","LU2468319806.SGD","XLV","LU1291159041.SGD","IE00B1BXHZ80.USD","LU1941712348.USD","LU2491049909.HKD","LU1162221912.USD","LU1989772923.USD","LU1066051225.USD","LU2023250843.SGD","LU1585245621.USD","BK4007","SG9999014567.USD","IE00BFTCPJ56.SGD","LU0265550359.USD","IE000M9KFDE8.USD","LU0234572021.USD","IE00BBT3K403.USD","LU0098860793.USD","LU2089984988.USD","SG9999001176.SGD","LU1430594728.SGD","BK4588","LU0130102774.USD","SG9999002232.USD","LU1066053197.SGD","IXJ","LU0130517989.USD","TRUH","LU2361044865.SGD","IHE","LU0689626769.HKD","LU1116320737.USD","LU2324357040.USD","LU0868494617.USD","RXL","BK4533","LU0980610538.SGD","LU0122379950.USD","LU1974910355.USD","LU1989772840.SGD","LU2125154935.USD","LU0070302665.USD","LU1201861249.SGD","SG9999014575.USD","LU2361044949.HKD","SG9999013999.USD","LU1941712264.USD","IE00BLSP4452.SGD","LU0265550946.USD","LU1069347547.HKD","LU1057294990.SGD","LU0238689110.USD","LU2125154778.USD","LU1037948897.HKD","LU1037948541.HKD","LU0320765489.SGD","LU0477156953.USD","LU0868494708.USD","IE0002141913.USD","LU0124676726.USD","BK4534","LU2106854487.HKD","FHLC","LU2361045086.USD","BK4585","LU0266013472.USD","SG9999015358.SGD","LU1929549753.HKD","LU2023250504.SGD","LU0861579265.USD","SG9999014542.SGD","LU1061106388.HKD","LU0203345920.USD","LU1066051498.USD","IE00B4R5TH58.HKD","LU1032466523.USD","IE00BLSP4239.USD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665281321","title":"Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146","url":"https://stock-news.laohu8.com/highlight/detail?id=2665281321","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665281321?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:15","pubTimestamp":1788862514,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0477156953.USD","LU2125909593.SGD","BMED","SG9999014567.USD","LU0124676726.USD","LU1037948897.HKD","LU0266013472.USD","LU0203345920.USD","LU1989772923.USD","LU1699723380.USD","LU0965508806.USD","BK4559","LU0234572021.USD","LU1585245621.USD","LU2023250843.SGD","LU1941712264.USD","LU1066051498.USD","LU0106261372.USD","LU1989771016.USD","BK4588","GDOC","LU0320765489.SGD","SG9999015358.SGD","BK4007","LU0861579265.USD","LU0868494708.USD","LU1116320737.USD","HRTS","BK4534","LU2361044949.HKD","LU2324357040.USD","BK4585","LU1941712348.USD","LU1430594728.SGD","LU1983299246.USD","LU0320765646.SGD","LU2023250504.SGD","IE0009355771.USD","IYH","IE00B4R5TH58.HKD","LU2089984988.USD","LU0965509283.SGD","LU1923622614.USD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU2125154778.USD","LU0211331839.USD","LU0823416689.USD","IE00BJT1NW94.SGD","LU1934455277.USD","LU2112291526.USD","IE00BLSP4452.SGD","LU1066051225.USD","LU1571399168.USD","IE00B1BXHZ80.USD","JDOC","LU1162221912.USD","LU0432979614.USD","LU1093756168.USD","LU0006306889.USD","LU0130517989.USD","LU2125154935.USD","LU0265550359.USD","LU0098860793.USD","LU1066051811.HKD","LU2491050154.USD","FHLC","PAWZ","LU0208291251.USD","LU0868494617.USD","LU0859254822.USD","SG9999013999.USD","IE000M9KFDE8.USD","LU1934455194.USD","LU0985320562.USD","LU0689626769.HKD","LU0203347892.USD","LU1929549753.HKD","LU0980610538.SGD","SG9999001176.SGD","LU0122379950.USD","SG9999015341.SGD","XLV","LU1974910355.USD","FTXH","LU1066053197.SGD","LU0058720904.USD","BK4550","LU2433249047.HKD","VHT","LU0648001328.SGD","LU2360032135.SGD","SGXZ57979304.SGD","LU0289739699.SGD","LU0070302665.USD","IE00BFTCPJ56.SGD","MRK","IXJ","LU0130102774.USD","LU0265550946.USD","SG9999014559.SGD","LU2106854487.HKD","LU0238689110.USD","LU1023059063.AUD","LU1116320901.HKD","LU2491049909.HKD","LU1093756325.SGD","LU1032466523.USD","IE00BLSP4239.USD","LU1917777945.USD","LU2461242641.AUD","SG9999001440.SGD","RXL","LU1061106388.HKD","PPH","LU2468319806.SGD","LU1037948541.HKD","LU0965509010.AUD","LU1989772840.SGD","BK4533","LU1035773651.USD","IE00BN8TJ469.HKD","TRUH","SG9999002232.USD","SG9999001176.USD","LU0942090050.USD","IE0002141913.USD","LU1201861249.SGD","LU2357627491.SGD","LU1069347547.HKD","LU2491050071.SGD","SG9999014575.USD","LU1934455863.HKD","LU0965509101.SGD","LU1291159041.SGD","SG9999014542.SGD","BK4516","IHE","LU2361045086.USD","IE00B2B36J28.USD","LU2125909247.SGD","LU2361044865.SGD","LU1057294990.SGD","IE00BSNM7G36.USD","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665601324","title":"MediciNova to Participate in Two Investor Conferences in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2665601324","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665601324?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:00","pubTimestamp":1788861600,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Sept.  08, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchang","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357430/7767/en/medicinova-to-participate-in-two-investor-conferences-in-september.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HYLG","IE00BZ1G4Q59.USD","LU0053666078.USD","LU0210528500.USD","LU1791710582.SGD","LU0795875169.SGD","LU2089284900.SGD","IE00B3S45H60.SGD","LU2028103732.USD","LU1791710400.SGD","NVIB","LU2133065610.SGD","BK4534","LU0971096721.USD","LU1548497426.USD","GDOC","IDNA","BK4516","LU0557290698.USD","LU2487616109.SGD","LU0912757837.SGD","LU1989772840.SGD","LU2347655156.SGD","BK4585","LU1064131342.USD","LU0006306889.USD","IE00BKVL7J92.USD","LU2264538146.SGD","BK4504","MNOV","BMED","LU0267386448.USD","LU1074936037.SGD","LU1720051108.HKD","LU0098860793.USD","KBWB","LU0106831901.USD","LU0390134368.USD","LU0528227936.USD","BK4127","MEDX","LU1720051017.SGD","BK4139","LU2111349929.HKD","IAI","LU1732799900.SGD","BK4588","LU0234570918.USD","LU2089283258.USD","LU1989772923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194747479","title":"Cholesterol Drug Trial Setback Casts Doubt on Multi-Billion Rivalry","url":"https://stock-news.laohu8.com/highlight/detail?id=1194747479","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194747479?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:40","pubTimestamp":1788860434,"startTime":"0","endTime":"0","summary":"Novartis's closely watched cardiovascular trial has failed, raising significant questions about one of the pharmaceutical industry's most prominent drug development races and casting uncertainty over...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","MDTX","IBBJ","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132147233","title":"Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1132147233","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132147233?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:20","pubTimestamp":1788859248,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SH: 600196) has announced that its controlling subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., recently received approval...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","MDTX","BK0183","BK1515","BK1593","IBBQ","BMED","600196","PSYK","BK0060","02196","BK0175","BK0188","BK0028","BK0096","BK0239","BK0196","IBBJ","BK0012","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125754221","title":"Pharmaceutical Giant's Shares Plunge Nearly 10% Following Triple Clinical Trial Setbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=1125754221","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125754221?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:00","pubTimestamp":1788858037,"startTime":"0","endTime":"0","summary":"Swiss pharmaceutical heavyweight Novartis faced a turbulent trading session on Tuesday as its shares tumbled sharply following the disclosure that its experimental drug for muscular dystrophy,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","BK4585","MDTX","BMED","BK4532","IE00BJT1NW94.SGD","NVS","BK4578","LU0070302665.USD","MEDX","IE00B2B36J28.USD","IE0002141913.USD","BK4007","PSYK","IE00BJJMRZ35.SGD","BK4588","IBBQ","PPH","IE00B4R5TH58.HKD","LU0208291251.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332552","title":"Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332552","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332552?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:30","pubTimestamp":1788856210,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Sanofi (SNYNF) and Merck & Company (MRK) with neutral ratings, indicating that the experts are neithe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","BK4588","LU1974910355.USD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0070302665.USD","IE00BFTCPJ56.SGD","LU1934455863.HKD","BMED","LU0006306889.USD","LU1061106388.HKD","LU1037948541.HKD","LU0477156953.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0234572021.USD","LU0130517989.USD","LU0130102774.USD","LU2433249047.HKD","LU2361045086.USD","LU1430594728.SGD","SG9999014542.SGD","SG9999001440.SGD","SG9999015358.SGD","LU1934455194.USD","LU0122379950.USD","LU2491050154.USD","BK4559","LU1066051498.USD","LU0965509283.SGD","LU1989772840.SGD","FHLC","LU1162221912.USD","SG9999015341.SGD","LU0965509101.SGD","LU2361044949.HKD","LU0432979614.USD","LU1035773651.USD","LU1116320737.USD","SG9999014559.SGD","LU0289739699.SGD","BK4550","LU0868494708.USD","LU1093756325.SGD","LU2106854487.HKD","IE00BJT1NW94.SGD","LU2125154778.USD","LU1057294990.SGD","LU1093756168.USD","LU0266013472.USD","LU1699723380.USD","IE00BSNM7G36.USD","LU2023250843.SGD","LU0648001328.SGD","LU1023059063.AUD","IHE","IE00B2B36J28.USD","LU0203347892.USD","LU0320765489.SGD","SG9999014575.USD","LU1571399168.USD","IE00B1BXHZ80.USD","IXJ","LU1066051811.HKD","LU1585245621.USD","LU0098860793.USD","LU0106261372.USD","LU0868494617.USD","LU2491049909.HKD","LU2125154935.USD","SG9999001176.USD","SG9999002224.SGD","SG9999014567.USD","LU1989771016.USD","LU1934455277.USD","IE00BBT3K403.USD","PPH","LU2324357040.USD","LU0861579265.USD","LU1037948897.HKD","IE000M9KFDE8.USD","LU1941712264.USD","LU1116320901.HKD","LU2023250504.SGD","LU0265550946.USD","BK4585","IE00BN8TJ469.HKD","LU0942090050.USD","PAWZ","LU0859254822.USD","LU0124676726.USD","LU1917777945.USD","LU1069347547.HKD","LU2461242641.AUD","SG9999002232.USD","LU2112291526.USD","LU0265550359.USD","BK4516","LU0689626769.HKD","LU0208291251.USD","IE0009355771.USD","LU0211331839.USD","LU1923622614.USD","LU0203345920.USD","LU1989772923.USD","JDOC","FTXH","LU0320765646.SGD","LU1032466523.USD","IYH","LU2089984988.USD","SG9999001176.SGD","LU2360032135.SGD","IE00B4R5TH58.HKD","LU0058720904.USD","SGXZ57979304.SGD","LU2357627491.SGD","MRK","RXL","LU1929549753.HKD","LU2125909247.SGD","IE00BJJMRZ35.SGD","LU1066051225.USD","BK4007","LU2361044865.SGD","LU0980610538.SGD","TRUH","LU0823416689.USD","BK4534","LU1983299246.USD","HRTS","LU1291159041.SGD","LU0965508806.USD","SNYNF","GDOC","LU1941712348.USD","IE0002141913.USD","LU0985320562.USD","LU2468319806.SGD","VHT","LU0238689110.USD","LU2125909593.SGD","LU0965509010.AUD","LU1201861249.SGD","LU2491050071.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179120005","title":"Medprin Regenerative Medical Technologies Advances Absorbable Hemostatic Gel to Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1179120005","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179120005?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:28","pubTimestamp":1788856093,"startTime":"0","endTime":"0","summary":"Medprin Regenerative Medical Technologies Co., Ltd. (301033.SZ) has officially announced that its research project involving the \"absorbable hemostatic fluid gelatin\" has recently entered the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","301033","IBBJ","IBBQ","BK0251","PSYK","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665097340","title":"Merck KGaA (0O14) Gets a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2665097340","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665097340?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:05","pubTimestamp":1788851124,"startTime":"0","endTime":"0","summary":"In a report released today, James Gordon CFA from Barclays maintained a Hold rating on Merck KGaA, with a price target of €150.00. According to Tip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/merck-kgaa-0o14-gets-a-hold-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/merck-kgaa-0o14-gets-a-hold-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1069347547.HKD","TRUH","LU2125909247.SGD","SG9999015341.SGD","PPH","RXL","LU1974910355.USD","LU1066051225.USD","LU2125154935.USD","BMED","SG9999001176.SGD","LU0868494617.USD","LU0289739699.SGD","LU0859254822.USD","LU2491050071.SGD","LU0098860793.USD","LU1066051811.HKD","LU2468319806.SGD","LU1057294990.SGD","LU1061106388.HKD","LU1023059063.AUD","LU2491049909.HKD","LU1585245621.USD","SG9999013999.USD","FTXH","HRTS","IYH","IE0002141913.USD","LU0965509010.AUD","LU0130102774.USD","LU2357627491.SGD","SG9999014542.SGD","IXJ","LU2324357040.USD","PAWZ","VHT","IE000M9KFDE8.USD","IE00BLSP4239.USD","BK4534","LU0965508806.USD","MRK","JDOC","CFA","IHE","XLV","FHLC","GDOC","LU0823416689.USD","SG9999014567.USD","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317041","title":"Gilead Sciences (GILD) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317041?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:25","pubTimestamp":1788798346,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences today and set a price target of $160.00. Breen covers the Healthcare se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","LU2468319806.SGD","BK4581","XBI","BMED","LU1037948541.HKD","LU1778281490.HKD","LU2089984988.USD","IE0002270589.USD","GILD","IE00B7SZLL34.SGD","IBB","LU1839511570.USD","LU0122379950.USD","XLV","LU0965508806.USD","LU0823416689.USD","LU1585245621.USD","SG9999015945.SGD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1934455277.USD","LU1066051498.USD","IE00B3T34201.USD","BK4550","LU1571399168.USD","LU1934455863.HKD","BK4578","BK4566","BK4588","LU0882574055.USD","SG9999015978.USD","LU1674673428.USD","LU0289739699.SGD","LABU","IE00B19Z3B42.SGD","LU2324357040.USD","BIB","BK4139","BBH","BK4585","SG9999015952.SGD","TBXU","IBBQ","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU0114720955.EUR","TMED","LU1934455194.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317069","title":"Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317069?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:21","pubTimestamp":1788798066,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultrageny...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-intellia-therapeutics-ntla-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-intellia-therapeutics-ntla-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","LU1116320901.HKD","LU1699723380.USD","LU0006306889.USD","LU0320765646.SGD","SG9999015358.SGD","LU2324357040.USD","LU2361044949.HKD","BK4588","LU1917777945.USD","LU1093756325.SGD","LU0058720904.USD","BK4550","LU1069347547.HKD","VHT","LU0689626769.HKD","LU1983299246.USD","SG9999001176.SGD","LU1989771016.USD","SG9999002224.SGD","LU0265550946.USD","LU1066051498.USD","SG9999015341.SGD","PAWZ","LU0124676726.USD","LU2361044865.SGD","NTLA","LU2089984988.USD","LU1430594728.SGD","LU1061106388.HKD","LU0965509010.AUD","LU1934455194.USD","SG9999013999.USD","LU2125154935.USD","SGXZ57979304.SGD","TRUH","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0648001328.SGD","BK4556","LU0965508806.USD","SG9999014567.USD","BK4535","LU0106261372.USD","LU0861579265.USD","SG9999014559.SGD","LU0868494617.USD","LU1934455277.USD","LU0859254822.USD","BK4533","IE0002141913.USD","LU0868494708.USD","MRK","IE0009355771.USD","LU0477156953.USD","LU1116320737.USD","LU1934455863.HKD","LU2491049909.HKD","SG9999001440.SGD","LU2023250504.SGD","LU1057294990.SGD","LU0289739699.SGD","LU0208291251.USD","LU1989772840.SGD","SG9999014575.USD","LU1941712264.USD","FTXH","LU2361045086.USD","GDOC","LU2125154778.USD","IE00BFTCPJ56.SGD","LU1861558580.USD","LU0942090050.USD","IE00BJJMRZ35.SGD","LU1929549753.HKD","LU2491050154.USD","LU2112291526.USD","LU1066051811.HKD","LU1989772923.USD","LU1585245621.USD","SG9999001176.USD","FHLC","BMED","LU1066053197.SGD","LU2491050071.SGD","LU0203347892.USD","LU0823416689.USD","RXL","LU2357627491.SGD","LU0432979614.USD","LU0980610538.SGD","LU2125909593.SGD","BK4559","IE00B1BXHZ80.USD","LU1162221912.USD","IYH","LU2023250843.SGD","LU2461242641.AUD","PPH","RARE","JDOC","LU0098860793.USD","IE00B2B36J28.USD","LU2106854487.HKD","LU2433249047.HKD","LU0965509101.SGD","IHE","LU0122379950.USD","LU2360032135.SGD","LU1035773651.USD","LU0234572021.USD","LU0265550359.USD","IE00BSNM7G36.USD","LU0203345920.USD","LU1861559042.SGD","LU1974910355.USD","BK4007","LU0238689110.USD","LU0965509283.SGD","LU1066051225.USD","LU0320765489.SGD","LU1032466523.USD","BK4139","SG9999002232.USD","IE00B4R5TH58.HKD","LU0211331839.USD","LU1037948897.HKD","IE00BJT1NW94.SGD","LU1201861249.SGD","LU2468319806.SGD","LU0070302665.USD","SG9999014542.SGD","LU1571399168.USD","LU1291159041.SGD","LU1037948541.HKD","LU2125909247.SGD","IE00BN8TJ469.HKD","LU0130102774.USD","LU0266013472.USD","LU0985320562.USD","IXJ","LU1941712348.USD","BK4585","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU1093756168.USD","HRTS","LU1923622614.USD","LU0130517989.USD","BK4534","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317747","title":"Aliko Scientific accelerates global oncology diagnostics push with Partner International deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317747","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317747?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:18","pubTimestamp":1788797881,"startTime":"0","endTime":"0","summary":"Ikonisys SA ( ($FR:ALIKO) ) has provided an announcement. Aliko Scientific, listed on Euronext Growth Paris, leads an international ecosystem dedic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aliko-scientific-accelerates-global-oncology-diagnostics-push-with-partner-international-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aliko-scientific-accelerates-global-oncology-diagnostics-push-with-partner-international-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199113939","title":"CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=1199113939","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199113939?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:36","pubTimestamp":1788780985,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the Phase II clinical trial of its SYH2085 tablet, designed for the treatment of uncomplicated influenza in adults, has formally commenced at the first clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226288253.USD","LU1226287792.SGD","IE00B543WZ88.USD","LU0315179316.USD","BMED","LU1152091168.USD","LU0067412154.USD","LU0072913022.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","LU1807302812.USD","PSYK","IE00BZ08YR35.GBP","IBBJ","LU1226287529.USD","IE0008368742.USD","IE0008369823.USD","LU1960683339.HKD","LU1226287875.USD","LU1951186391.HKD","LU0314109678.HKD","LU0326950275.SGD","LU1008478684.HKD","BK1521","LU0880133367.SGD","LU1152091754.HKD","BK1515","IBBQ","IE00BZ08YS42.EUR","LU0140636845.USD","LU1226288170.HKD","IE00BZ08YT58.USD","LU1813983027.USD","LU1328277881.USD","01093","KURE","BK1191","SG9999004220.SGD","IE00B031HY20.USD","HK0000165453.HKD","LU2039709279.SGD","LU0501845795.SGD","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187160052","title":"HENGRUI PHARMA Advances Pipeline with SHR-1179 Injection Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1187160052","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187160052?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:52","pubTimestamp":1788778333,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (01276) has announced that its subsidiary, Guangdong Hengrui Pharmaceutical Co., Ltd., has recently received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327494.USD","MDTX","LU1328615791.USD","LU2289578879.USD","BK0012","BMED","BK0060","LU2580892862.HKD","LU2580892789.USD","IBBQ","LU0359201885.HKD","LU0359201612.USD","LU2097828714.EUR","LU1064131003.USD","LU1255011170.USD","LU1781817850.SGD","BK0188","LU1064130708.USD","LU1146622755.USD","LU1580142542.USD","LU2543165471.USD","BK0028","LU1969619763.USD","600276","01276","BK0196","LU1655091616.SGD","LU0359202008.SGD","LU2097828631.EUR","PSYK","BK0183","LU1997245177.USD","LU2097828557.USD","LU2488822045.USD","LU1023057109.AUD","LU2097828474.EUR","LU2495084118.USD","BK0239","IBBJ","BK1191","LU1997245094.SGD","LU0405327148.USD","LU1820825898.SGD","LU2328871848.SGD","LU1997244956.HKD","LU2097828805.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110897642","title":"Hengrui Pharma Subsidiary Gains Clinical Trial Approval for Weight Management Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1110897642","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110897642?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:22","pubTimestamp":1788772938,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SH: 600276) has announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., recently received the Drug Clinical Trial Approval Notice issued...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","BK0060","LU2580892789.USD","LU1328615791.USD","BK0239","LU0359202008.SGD","LU2289578879.USD","LU0405327494.USD","LU2097828631.EUR","LU1997245094.SGD","LU1781817850.SGD","LU2328871848.SGD","LU0359201612.USD","BK0012","LU1255011170.USD","LU2097828557.USD","IBBQ","LU1997245177.USD","LU2495084118.USD","LU1820825898.SGD","LU1655091616.SGD","LU1064130708.USD","BK1191","LU2097828474.EUR","LU2488822045.USD","LU1969619763.USD","LU2148510915.USD","BK0028","LU0405327148.USD","LU1023057109.AUD","LU0359201885.HKD","600276","BK0196","LU2097828805.USD","LU1997244956.HKD","LU1146622755.USD","01276","BK0188","BK0183","BMED","LU1064131003.USD","MDTX","IBBJ","PSYK","LU1580142542.USD","LU2097828714.EUR","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176376860","title":"Chongqing Zhifei Biological Receives Clinical Trial Approval for Recombinant Rotavirus Subunit Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1176376860","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176376860?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:20","pubTimestamp":1788772824,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products Co.,Ltd. (300122.SZ) has announced that its wholly-owned subsidiary, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd., has obtained a drug clinical trial approval...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BMED","BK0188","BK0046","159646","BK0196","IBBQ","LU1064130708.USD","BK0077","BK0239","LU2148510915.USD","PSYK","LU2580892789.USD","MDTX","LU1064131003.USD","IBBJ","LU2580892862.HKD","300122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162474456","title":"Hualan Vaccine's Novel Influenza mRNA Vaccine Clears Clinical Trial Hurdle, No Domestic Competitors Yet","url":"https://stock-news.laohu8.com/highlight/detail?id=1162474456","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162474456?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:51","pubTimestamp":1788771108,"startTime":"0","endTime":"0","summary":"Hualan Biological Vaccine Inc. (301207.SZ) announced it has received the \"Drug Clinical Trial Approval Notice\" from the National Medical Products Administration for its novel influenza virus mRNA...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301207","MRNX","MDTX","BK0239","IBBQ","BMED","MRNY","IPOS","IBBJ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131915744","title":"Gan&Lee Pharmaceuticals Begins Phase I Dosing in GZC8072 Obesity and Diabetes Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1131915744","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131915744?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:56","pubTimestamp":1788767798,"startTime":"0","endTime":"0","summary":"Gan&Lee Pharmaceuticals (SH: 603087) has announced that its wholly-owned subsidiary, Gan&Lee Pharmaceuticals Shandong Co., Ltd., has successfully administered the first dose to a volunteer in a Phase...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IBBQ","PSYK","BK0239","603087","MDTX","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314395","title":"Vitura hit by BUPA telehealth shift but reiterates FY2027 growth outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314395","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665314395?lang=en_us&edition=fundamental","pubTime":"2026-09-07 10:17","pubTimestamp":1788747434,"startTime":"0","endTime":"0","summary":"Cronos Australia Ltd. ( ($AU:VIT) ) just unveiled an announcement. Vitura Health has disclosed a material setback for its Doctors on Demand telehea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vitura-hit-by-bupa-telehealth-shift-but-reiterates-fy2027-growth-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vitura-hit-by-bupa-telehealth-shift-but-reiterates-fy2027-growth-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","EKG","HEAL","ANEW","HTEC","BMED","LGHT","FDIF"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":8,"totalSize":202,"code":"91000000","status":"200"}]}}